As of 2025-10-04, the EV/EBITDA ratio of Dr. Lal PathLabs Ltd (LALPATHLAB.NS) is 32.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LALPATHLAB.NS's latest enterprise value is 253,968.55 mil INR. LALPATHLAB.NS's TTM EBITDA according to its financial statements is 7,890.31 mil INR. Dividing these 2 quantities gives us the above LALPATHLAB.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 23.7x | 16.5x |
| Forward P/E multiples | 10.3x - 29.0x | 20.4x |
| Fair Price | 960.97 - 2,804.42 | 1,815.69 |
| Upside | -69.2% - -10.3% | -41.9% |
| Date | EV/EBITDA |
| 2025-10-03 | 32.19 |
| 2025-10-01 | 32.47 |
| 2025-09-30 | 32.19 |
| 2025-09-29 | 32.29 |
| 2025-09-26 | 32.88 |
| 2025-09-25 | 33.31 |
| 2025-09-24 | 34.20 |
| 2025-09-23 | 34.36 |
| 2025-09-22 | 34.99 |
| 2025-09-19 | 35.33 |
| 2025-09-18 | 33.85 |
| 2025-09-17 | 33.67 |
| 2025-09-16 | 33.69 |
| 2025-09-15 | 34.00 |
| 2025-09-12 | 34.28 |
| 2025-09-11 | 33.72 |
| 2025-09-10 | 33.47 |
| 2025-09-09 | 32.66 |
| 2025-09-08 | 33.18 |
| 2025-09-05 | 33.51 |
| 2025-09-04 | 34.09 |
| 2025-09-03 | 34.44 |
| 2025-09-02 | 33.31 |
| 2025-09-01 | 33.77 |
| 2025-08-29 | 34.20 |
| 2025-08-28 | 34.28 |
| 2025-08-26 | 34.20 |
| 2025-08-25 | 34.62 |
| 2025-08-22 | 34.88 |
| 2025-08-21 | 34.98 |
| 2025-08-20 | 35.65 |
| 2025-08-19 | 34.83 |
| 2025-08-18 | 35.48 |
| 2025-08-14 | 34.61 |
| 2025-08-13 | 33.99 |
| 2025-08-12 | 33.55 |
| 2025-08-11 | 33.14 |
| 2025-08-08 | 32.84 |
| 2025-08-07 | 32.98 |
| 2025-08-06 | 33.03 |
| 2025-08-05 | 32.78 |
| 2025-08-04 | 31.93 |
| 2025-08-01 | 32.72 |
| 2025-07-31 | 32.45 |
| 2025-07-30 | 31.93 |
| 2025-07-29 | 31.24 |
| 2025-07-28 | 31.08 |
| 2025-07-25 | 31.69 |
| 2025-07-24 | 31.71 |
| 2025-07-23 | 31.03 |